| Symbol | EQ |
|---|---|
| Name | EQUILLIUM, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 2223 AVENIDA DE LA PLAYA,SUITE 105, LA JOLLA, California, 92037, United States |
| Telephone | +1 858 240-1200 |
| Fax | — |
| — | |
| Website | https://www.equilliumbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001746466 |
| Description | Equillium Inc is a biotechnology developing therapies to treat autoimmune and inflammatory disorders. Its pipeline includes itolizumab, a first-in-class antibody targeting the CD6-ALCAM pathway which plays a key role in the modulation of effector T cells - currently in a Ph 3 study for patients with acute graft-versus-host disease and a Ph 1b study for patients with lupus nephritis. EQ101, a first-in-class cytokine inhibitor that selectively targets IL-2, IL-9, and IL-15 is Ph 2 ready and expected to begin enrolling patients in an alopecia areata study in 2H 2022. EQ102, a cytokine inhibitor that selectively targets IL-15 and IL-21, is ready for clinical development and expected to begin enrolling patients in a Ph 1study including patients with celiac disease. Additional info from NASDAQ: |
📋 Connelly Stephen (Officer) plans to sell 31K shares of Equillium, Inc. (at $2.94 each, total $91K) Filed: Jun 05, 2026 | ID: 000073
Read moreZedelmayer Christine 🟡 adjusted position in 14.6K shares (1 derivative) of Equillium, Inc. (EQ) at $2.93 Transaction Date: Jun 05, 2026 | Filing ID: 000011
Read moreConnelly Stephen 🔴 sold 231.0K shares of Equillium, Inc. (EQ) at $3.16 Transaction Date: Jun 04, 2026 | Filing ID: 000004
Read more📋 Connelly Stephen (Officer) plans to sell 200K shares of Equillium, Inc (at $3.16 each, total $633K) Filed: Jun 04, 2026 | ID: 000071
Read moreEquillium - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreTom Penny 🟡 adjusted position in 65.0K shares (1 derivative) of Equillium, Inc. (EQ) at $2.95 Transaction Date: May 28, 2026 | Filing ID: 000002
Read moreDEMSKI MARTHA J 🟢 acquired 70.0K shares (1 derivative) of Equillium, Inc. (EQ) at $2.84 Transaction Date: May 28, 2026 | Filing ID: 000003
Read morePruzanski Mark 🟢 acquired 70.0K shares (1 derivative) of Equillium, Inc. (EQ) at $2.84 Transaction Date: May 28, 2026 | Filing ID: 000001
Read moreBRADBURY DANIEL 🟢 acquired 70.0K shares (1 derivative) of Equillium, Inc. (EQ) at $2.84 Transaction Date: May 28, 2026 | Filing ID: 000003
Read more